Search research articles
Contact Us
Filters
Showing results (111-120 of 177) with videos related to
Page
of 18
Sort By:
Antimicrobial Agents and Chemotherapy
|
December 7, 2011
Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline
Sujata M Bhavnani, Christopher M Rubino, Jeffrey P Hammel, et al.
Journal of Clinical Pharmacology
|
August 3, 2013
Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia
Scott A Van Wart, Alan Forrest, Tatiana Khariton, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2017
Critical Need for Clarity in Polymyxin B Dosing
Nikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Pharmacotherapy
|
December 1, 2010
Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing
Lauren M Lim, Neang Ly, Dana Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 25, 2016
Dosing guidance for intravenous colistin in critically-ill patients
Roger L Nation, Samira M Garonzik, Visanu Thamlikitkul, et al.
Antimicrobial Agents and Chemotherapy
|
August 31, 2011
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula
Phillip J Bergen, Alan Forrest, Jürgen B Bulitta, et al.
Plos One
|
October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design
Micaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2012
Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations
Brian T Tsuji, Jurgen B Bulitta, Tanya Brown, et al.
Pharmacotherapy
|
January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use
Phillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2016
Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models
Catharine C Bulik, Ólanrewaju O Okusanya, Elizabeth A Lakota, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 177) with videos related to
Sort By:
Page
of 18
Antimicrobial Agents and Chemotherapy
|
December 7, 2011
Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline
Sujata M Bhavnani, Christopher M Rubino, Jeffrey P Hammel, et al.
Journal of Clinical Pharmacology
|
August 3, 2013
Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia
Scott A Van Wart, Alan Forrest, Tatiana Khariton, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2017
Critical Need for Clarity in Polymyxin B Dosing
Nikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
Pharmacotherapy
|
December 1, 2010
Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing
Lauren M Lim, Neang Ly, Dana Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 25, 2016
Dosing guidance for intravenous colistin in critically-ill patients
Roger L Nation, Samira M Garonzik, Visanu Thamlikitkul, et al.
Antimicrobial Agents and Chemotherapy
|
August 31, 2011
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula
Phillip J Bergen, Alan Forrest, Jürgen B Bulitta, et al.
Plos One
|
October 14, 2015
Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design
Micaela B Reddy, Kuo-Hsiung Yang, Gauri Rao, et al.
The Journal of Antimicrobial Chemotherapy
|
June 12, 2012
Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations
Brian T Tsuji, Jurgen B Bulitta, Tanya Brown, et al.
Pharmacotherapy
|
January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use
Phillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2016
Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models
Catharine C Bulik, Ólanrewaju O Okusanya, Elizabeth A Lakota, et al.
Page
of 18